TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
OMER

Omeros Corporation

Healthcare · Biotechnology

18.50$ +6.4% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Omeros Corporation (OMER)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 95.7% of the shares are freely tradable; institutional investors hold 44.5%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 44.5%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 3.6%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 95.7%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 18.3%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 72Mio.

Largest Shareholders

Institutions

Institutions OMER
Name Stake (%) Shares Change (%) Date
BlackRock Inc 7.33 5,309,626 +4.9 03/31/2026
Ingalls & Snyder LLC 4.92 3,559,423 +3.2 03/31/2026
Vanguard Capital Management, LLC 4.12 2,983,259 +0.0 03/31/2026
UBS Group AG 3.23 2,340,731 +5.3 03/31/2026
State Street Corp 2.65 1,919,575 +22.0 03/31/2026
Stifel Financial Corp 2.53 1,831,585 +1.2 03/31/2026
Geode Capital Management, LLC 2.42 1,752,323 +7.4 03/31/2026

Funds

Funds OMER
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 3.00 2,172,336 +0.0 07/31/2026
iShares Russell 2000 ETF 2.55 1,848,893 -0.6 08/31/2026
Invesco Biotechnology & Genome ETF 1.28 929,585 +17.6 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings OMER
Person Role Shares Value As of Type
Cable Thomas J. Director 35,067 648,740 $ Aug 20, 2026 direct
Cancelmo Peter B VP, General Counsel 200 3,700 $ Aug 31, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 31, 2026 Cancelmo Peter B VP, General Counsel Sell 25,000 18.54 463,540
Aug 31, 2026 Cancelmo Peter B VP, General Counsel Other 25,000 2.94 73,500
Aug 28, 2026 Cancelmo Peter B VP, General Counsel Sell 25,000 18.65 466,128
Aug 28, 2026 Cancelmo Peter B VP, General Counsel Other 25,000 2.94 73,500
Aug 27, 2026 Hanish Arnold C Director Sell 5,000 19.02 95,081
Aug 27, 2026 Hanish Arnold C Director Other 7,500 14.66 109,950
Aug 27, 2026 Hanish Arnold C Director Other 2,500 15.81 39,525
Aug 26, 2026 Hanish Arnold C Director Sell 5,000 18.53 92,633
Aug 26, 2026 Hanish Arnold C Director Other 5,000 15.81 79,050
Aug 24, 2026 Borges David J. VP, Finance & CAO Sell 906 19.10 17,305
Aug 24, 2026 Borges David J. VP, Finance & CAO Other 906 2.94 2,664
Aug 21, 2026 Borges David J. VP, Finance & CAO Sell 10,000 18.95 189,500
Aug 21, 2026 Borges David J. VP, Finance & CAO Other 4,094 2.94 12,036
Aug 21, 2026 Borges David J. VP, Finance & CAO Other 5,906 3.93 23,211
Aug 20, 2026 Cable Thomas J. Director Sell 15,000 18.45 276,773
Aug 20, 2026 Cable Thomas J. Director Other 7,500 3.93 29,475
Aug 13, 2026 Borges David J. VP, Finance & CAO Sell 5,000 16.95 84,750
Aug 13, 2026 Borges David J. VP, Finance & CAO Other 5,000 3.93 19,650

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?